In light of underdiagnosis of bone loss in CKD-MBD, an elevated circulating level of adiponectin serves as an early warning sign for timely correction of mineral dysregulation and appropriate bone survey to prevent BF events in the high risk MHD population. This evidence concerns the gene ADIPOQ and Marchiafava-Bignami disease.